283 related articles for article (PubMed ID: 15668191)
1. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester.
Lee GY; Chang TS; Lee KS; Khil LY; Kim D; Chung JH; Kim YC; Lee BH; Moon CH; Moon CK
Thromb Res; 2005; 115(4):309-18. PubMed ID: 15668191
[TBL] [Abstract][Full Text] [Related]
2. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
3. Effects of Brazilin on the phospholipase A2 activity and changes of intracellular free calcium concentration in rat platelets.
Hwang GS; Kim JY; Chang TS; Jeon SD; So DS; Moon CK
Arch Pharm Res; 1998 Dec; 21(6):774-8. PubMed ID: 9868555
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
6. Effects of Brx-019 (acetic acid 3,6a,9-triacetoxy-6,6a,7, 11b-tetrahydro-indeno [2,1-c] chromen-10-yl ester), a Brazilin derivative, on T cell-mediated immune responses in multiple low dose streptozotocin-induced diabetic C57BL/6 male mice.
Kwak WJ; Kim MH; Jeon SD; Khil LY; Chae SH; Kim D; Lee BH; Moon CK
Arzneimittelforschung; 2005; 55(9):541-8. PubMed ID: 16229119
[TBL] [Abstract][Full Text] [Related]
7. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
9. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity.
Jin YR; Han XH; Zhang YH; Lee JJ; Lim Y; Chung JH; Yun YP
Atherosclerosis; 2007 Sep; 194(1):144-52. PubMed ID: 17092506
[TBL] [Abstract][Full Text] [Related]
12. XC 386: a new antiplatelet agent.
Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet effect of hsien-ho-t'sao (Agrimonia pilosa).
Wang JP; Hsu MF; Teng CM
Am J Chin Med; 1985; 13(1-4):109-18. PubMed ID: 3927704
[TBL] [Abstract][Full Text] [Related]
15. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
16. Effects of trifluoperazine on platelet activation.
Ardlie NG; Boatwright C; Garrett J; McGuiness JA
Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
[TBL] [Abstract][Full Text] [Related]
17. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor.
Lee KS; Jin YR; Lee JJ; Lim Y; Son DJ; Lee CK; Yi KY; Yoo SE; Shin HS; Yun YP
Pharmacol Res; 2006 Mar; 53(3):265-70. PubMed ID: 16420980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
